“Tapinarof Cream 1% Once Daily: Consistent Efficacy Across Age Groups for Children Down to 2 Years of Age with Atopic Dermatitis in Two Pivotal Phase 3 Trials”, J of Skin, vol. 9, no. 6, p. s626, Nov. 2025, doi: 10.25251/9k281951.